HuR interacts with human immunodeficiency virus type 1 reverse transcriptase, and modulates reverse transcription in infected cells. 2008

Julie Lemay, and Priscilla Maidou-Peindara, and Thomas Bader, and Eric Ennifar, and Jean-Christophe Rain, and Richard Benarous, and Lang Xia Liu
Institut Cochin, Université Paris Descartes, CNRS (UMR8104), Paris, France. julie.lemay@kispi.uzh.ch

Reverse transcription of the genetic material of human immunodeficiency virus type 1 (HIV-1) is a critical step in the replication cycle of this virus. This process, catalyzed by reverse transcriptase (RT), is well characterized at the biochemical level. However, in infected cells, reverse transcription occurs in a multiprotein complex - the reverse transcription complex (RTC) - consisting of viral genomic RNA associated with viral proteins (including RT) and, presumably, as yet uncharacterized cellular proteins. Very little is known about the cellular proteins interacting with the RTC, and with reverse transcriptase in particular. We report here that HIV-1 reverse transcription is affected by the levels of a nucleocytoplasmic shuttling protein - the RNA-binding protein HuR. A direct protein-protein interaction between RT and HuR was observed in a yeast two-hybrid screen and confirmed in vitro by homogenous time-resolved fluorescence (HTRF). We mapped the domain interacting with HuR to the RNAse H domain of RT, and the binding domain for RT to the C-terminus of HuR, partially overlapping the third RRM RNA-binding domain of HuR. HuR silencing with specific siRNAs greatly impaired early and late steps of reverse transcription, significantly inhibiting HIV-1 infection. Moreover, by mutagenesis and immunoprecipitation studies, we could not detect the binding of HuR to the viral RNA. These results suggest that HuR may be involved in and may modulate the reverse transcription reaction of HIV-1, by an as yet unknown mechanism involving a protein-protein interaction with HIV-1 RT.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067780 ELAV-Like Protein 1 An RRM protein that binds to the 3'-UTR region of mRNAs and increases their stability. In EMBRYONIC STEM CELLS, it binds to poly-U elements and AU-rich elements (AREs) in the 3'-UTR of target mRNAs and preferentially binds mRNAs that are not methylated by N6-methyladenosine (m6A), to stabilize them and promote differentiation. ELAVL1 protein,HuR Antigen,HuR Paraneoplastic Encephalomyelitis Antigen,HuR Protein,Antigen, HuR,ELAV Like Protein 1,Protein, HuR,protein, ELAVL1
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015200 Fluoroimmunoassay The use of fluorescence spectrometry to obtain quantitative results for the FLUORESCENT ANTIBODY TECHNIQUE. One advantage over the other methods (e.g., radioimmunoassay) is its extreme sensitivity, with a detection limit on the order of tenths of microgram/liter. Immunofluorometric Assay,Time-Resolved Immunofluorometric Assay,Assay, Immunofluorometric,Assay, Time-Resolved Immunofluorometric,Assays, Immunofluorometric,Assays, Time-Resolved Immunofluorometric,Fluoroimmunoassays,Immunofluorometric Assay, Time-Resolved,Immunofluorometric Assays,Immunofluorometric Assays, Time-Resolved,Time Resolved Immunofluorometric Assay,Time-Resolved Immunofluorometric Assays
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D016601 RNA-Binding Proteins Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA. Double-Stranded RNA-Binding Protein,Double-Stranded RNA-Binding Proteins,ds RNA-Binding Protein,RNA-Binding Protein,ds RNA-Binding Proteins,Double Stranded RNA Binding Protein,Double Stranded RNA Binding Proteins,Protein, Double-Stranded RNA-Binding,Protein, ds RNA-Binding,RNA Binding Protein,RNA Binding Proteins,RNA-Binding Protein, Double-Stranded,RNA-Binding Protein, ds,RNA-Binding Proteins, Double-Stranded,ds RNA Binding Protein

Related Publications

Julie Lemay, and Priscilla Maidou-Peindara, and Thomas Bader, and Eric Ennifar, and Jean-Christophe Rain, and Richard Benarous, and Lang Xia Liu
January 1996, Advances in virus research,
Julie Lemay, and Priscilla Maidou-Peindara, and Thomas Bader, and Eric Ennifar, and Jean-Christophe Rain, and Richard Benarous, and Lang Xia Liu
February 1996, Biological chemistry Hoppe-Seyler,
Julie Lemay, and Priscilla Maidou-Peindara, and Thomas Bader, and Eric Ennifar, and Jean-Christophe Rain, and Richard Benarous, and Lang Xia Liu
April 2001, Journal of virology,
Julie Lemay, and Priscilla Maidou-Peindara, and Thomas Bader, and Eric Ennifar, and Jean-Christophe Rain, and Richard Benarous, and Lang Xia Liu
January 2000, Journal of human virology,
Julie Lemay, and Priscilla Maidou-Peindara, and Thomas Bader, and Eric Ennifar, and Jean-Christophe Rain, and Richard Benarous, and Lang Xia Liu
January 2004, Current topics in medicinal chemistry,
Julie Lemay, and Priscilla Maidou-Peindara, and Thomas Bader, and Eric Ennifar, and Jean-Christophe Rain, and Richard Benarous, and Lang Xia Liu
January 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
Julie Lemay, and Priscilla Maidou-Peindara, and Thomas Bader, and Eric Ennifar, and Jean-Christophe Rain, and Richard Benarous, and Lang Xia Liu
January 1995, Methods in enzymology,
Julie Lemay, and Priscilla Maidou-Peindara, and Thomas Bader, and Eric Ennifar, and Jean-Christophe Rain, and Richard Benarous, and Lang Xia Liu
April 1993, Molecular pharmacology,
Julie Lemay, and Priscilla Maidou-Peindara, and Thomas Bader, and Eric Ennifar, and Jean-Christophe Rain, and Richard Benarous, and Lang Xia Liu
July 1991, Proceedings of the National Academy of Sciences of the United States of America,
Julie Lemay, and Priscilla Maidou-Peindara, and Thomas Bader, and Eric Ennifar, and Jean-Christophe Rain, and Richard Benarous, and Lang Xia Liu
August 1992, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!